Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Demets

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDST R Fleming, J D Neaton, A Goldman, et al.
The New England Journal of Medicine|April 28, 1977
A co-operative study for the detection of the carrier state of classic hemophiliaH G Klein, L M Aledort, B N Bouma, et al.
Journal of the National Cancer Institute|August 15, 1990
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancerR R Love, P A Newcomb, D A Wiebe, et al.
Annals of Epidemiology|August 1, 1991
Issues in the early termination of the aspirin component of the Physicians' Health Study. Data Monitoring Board of the Physicians' Health StudyJ Cairns, L Cohen, T Colton, et al.
Annals of Internal Medicine|December 1, 1991
Effects of tamoxifen on cardiovascular risk factors in postmenopausal womenR R Love, D A Wiebe, P A Newcomb, et al.
The New England Journal of Medicine|March 26, 1992
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancerR R Love, R B Mazess, H S Barden, et al.
The New England Journal of Medicine|July 8, 1976
Randomized clinical trials. Perspectives on some recent ideasD P Byar, R M Simon, W T Friedewald, et al.
Controlled Clinical Trials|October 2, 2001
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshopV G De Gruttola, P Clax, D L DeMets, et al.
Controlled Clinical Trials|December 1, 1995
The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trialsD L DeMets, T R Fleming, R J Whitley, et al.
The New England Journal of Medicine|December 17, 1998
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial InvestigatorsJ N Cohn, S O Goldstein, B H Greenberg, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDST R Fleming, J D Neaton, A Goldman, et al.
The New England Journal of Medicine|April 28, 1977
A co-operative study for the detection of the carrier state of classic hemophiliaH G Klein, L M Aledort, B N Bouma, et al.
Journal of the National Cancer Institute|August 15, 1990
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancerR R Love, P A Newcomb, D A Wiebe, et al.
Annals of Epidemiology|August 1, 1991
Issues in the early termination of the aspirin component of the Physicians' Health Study. Data Monitoring Board of the Physicians' Health StudyJ Cairns, L Cohen, T Colton, et al.
Annals of Internal Medicine|December 1, 1991
Effects of tamoxifen on cardiovascular risk factors in postmenopausal womenR R Love, D A Wiebe, P A Newcomb, et al.
The New England Journal of Medicine|March 26, 1992
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancerR R Love, R B Mazess, H S Barden, et al.
The New England Journal of Medicine|July 8, 1976
Randomized clinical trials. Perspectives on some recent ideasD P Byar, R M Simon, W T Friedewald, et al.
Controlled Clinical Trials|October 2, 2001
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshopV G De Gruttola, P Clax, D L DeMets, et al.
Controlled Clinical Trials|December 1, 1995
The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trialsD L DeMets, T R Fleming, R J Whitley, et al.
The New England Journal of Medicine|December 17, 1998
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial InvestigatorsJ N Cohn, S O Goldstein, B H Greenberg, et al.
Pageof 9